Personalized Medicine Conference Highlights Progress in Cancer Therapies
Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine joined other renowned Florida cancer centers hosting the 2nd Annual Beyond the Promise: Addressing Evidence and Value in Personalized Medicine Conference in Tampa Oct. 2 and 3. Scientists from Sylvester, along with UF Health Cancer Center, Moffitt Cancer Center and the Florida Society of Clinical Oncology as well as guest speakers from esteemed institutions such as UT Southwestern Medical Center and Johns Hopkins University discussed the latest advances in personalized cancer medicine.
“I found the conference amazingly interesting,” said Sylvester Deputy Director Marc Lippman, M.D., a conference planning committee member, who spoke about patient selection for breast cancer therapies in the genomic era. “I particularly enjoyed hearing about the evolution of therapies in tumor types I manage less frequently such as sarcoma, colorectal and lung cancer.”
The goal of the annual conference is to provide a broad overview of efforts to bring precision cancer care to patients with solid tumors and hematologic malignancies as well as to discuss opportunities and challenges in the delivery of this care for patients and physicians across Florida.
“The conference brought together the best and brightest researchers who are leading the effort of precision medicine in the state,” said Tan A. Ince, M.D., Ph.D., researcher at Sylvester and associate professor of pathology at the Miller School. “For me and my research team, it was a great way of meeting potential collaborators at other Florida institutions. We hope to have the conference in Miami soon.”